N

Neuvivo

8 employees

Neuvivo is a late clinical-stage biopharmaceutical company developing a new ALS treatment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2020

Funding rounds raised

Total raised

$11M

from 1 investors over 1 rounds

N

Neuvivo raised $11M on June 15, 2023

Investors: PrimeStreet Advisory (Thailand) Co.,Ltd.

FAQ